Search research articles
Contact Us
Filters
Showing results (1-10 of 62) with videos related to
Page
of 7
Sort By:
Clinical Pharmacology and Therapeutics
|
March 25, 2015
Medicinal chemistry of cannabinoids
V Kiran Vemuri, A Makriyannis
Physiology & Behavior
|
December 25, 2007
Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome
V Kiran Vemuri, David R Janero, Alexandros Makriyannis
Tetrahedron Letters
|
March 29, 2011
The Conformations of 17β-Estradiol (E2) and 17α-Estradiol as Determined by Solution NMR
Jianxin Guo, Richard I Duclos, V Kiran Vemuri, et al.
Expert Opinion on Drug Discovery
|
June 1, 2012
Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk
David R Janero, Loren Lindsley, Venkata Kiran Vemuri, et al.
Current Topics in Medicinal Chemistry
|
August 22, 2006
The cannabinergic system as a target for anti-inflammatory therapies
Dai Lu, V Kiran Vemuri, Richard I Duclos, et al.
Physiology & Behavior
|
December 14, 2007
Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties
Jack Bergman, Marcus S Delatte, Carol A Paronis, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 10, 2018
Long-Lasting In Vivo Effects of the Cannabinoid CB1 Antagonist AM6538
Carol A Paronis, Girish R Chopda, Kiran Vemuri, et al.
Journal of Psychopharmacology (Oxford, England)
|
March 24, 2016
CB1 antagonism produces behaviors more consistent with satiety than reduced reward value in food-maintained responding in rats
Emily E Thompson, Julia E Jagielo-Miller, V Kiran Vemuri, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 2012
Analysis of tolerance and behavioral/physical dependence during chronic CB1 agonist treatment: effects of CB1 agonists, antagonists, and noncannabinoid drugs
Rajeev I Desai, Ganesh A Thakur, V Kiran Vemuri, et al.
Behavioral Neuroscience
|
July 18, 2017
CB₁ receptor antagonism in the bed nucleus of the stria terminalis interferes with affective opioid withdrawal in rats
Kiri L Wills, Marieka V DeVuono, Cheryl L Limebeer, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 62) with videos related to
Sort By:
Page
of 7
Clinical Pharmacology and Therapeutics
|
March 25, 2015
Medicinal chemistry of cannabinoids
V Kiran Vemuri, A Makriyannis
Physiology & Behavior
|
December 25, 2007
Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome
V Kiran Vemuri, David R Janero, Alexandros Makriyannis
Tetrahedron Letters
|
March 29, 2011
The Conformations of 17β-Estradiol (E2) and 17α-Estradiol as Determined by Solution NMR
Jianxin Guo, Richard I Duclos, V Kiran Vemuri, et al.
Expert Opinion on Drug Discovery
|
June 1, 2012
Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk
David R Janero, Loren Lindsley, Venkata Kiran Vemuri, et al.
Current Topics in Medicinal Chemistry
|
August 22, 2006
The cannabinergic system as a target for anti-inflammatory therapies
Dai Lu, V Kiran Vemuri, Richard I Duclos, et al.
Physiology & Behavior
|
December 14, 2007
Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties
Jack Bergman, Marcus S Delatte, Carol A Paronis, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 10, 2018
Long-Lasting In Vivo Effects of the Cannabinoid CB1 Antagonist AM6538
Carol A Paronis, Girish R Chopda, Kiran Vemuri, et al.
Journal of Psychopharmacology (Oxford, England)
|
March 24, 2016
CB1 antagonism produces behaviors more consistent with satiety than reduced reward value in food-maintained responding in rats
Emily E Thompson, Julia E Jagielo-Miller, V Kiran Vemuri, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 2012
Analysis of tolerance and behavioral/physical dependence during chronic CB1 agonist treatment: effects of CB1 agonists, antagonists, and noncannabinoid drugs
Rajeev I Desai, Ganesh A Thakur, V Kiran Vemuri, et al.
Behavioral Neuroscience
|
July 18, 2017
CB₁ receptor antagonism in the bed nucleus of the stria terminalis interferes with affective opioid withdrawal in rats
Kiri L Wills, Marieka V DeVuono, Cheryl L Limebeer, et al.
Page
of 7